CooperCompanies Completes Acquisition of Generate Life Sciences®

SAN RAMON, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) — CooperCompanies (NYSE: COO) today announced it has completed the previously announced definitive purchase agreement to acquire Generate Life Sciences, a leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood & cord tissue), for a purchase price of approximately $1.6 billion.

“We are excited to complete this transaction and welcome the Generate employees to the Cooper family,” said Al White, Cooper’s President and CEO. “By adding Generate to CooperSurgical we are able to provide fertility clinics and Ob/Gyns an even stronger offering and we look forward to delivering these products and services with our newly added team members.”

In connection with the transaction, Cooper also announced it has closed a $1.5 billion non-amortizing 5-year Senior Unsecured Term Loan. The Company intends to use the facility to fund the acquisition.